• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA CASC11 通过 microRNA-150 促进膀胱癌中的癌细胞增殖。

lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150.

机构信息

Department of Urology, Tongji Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.

Department of General Surgery, Tongji Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.

出版信息

J Cell Biochem. 2019 Aug;120(8):13487-13493. doi: 10.1002/jcb.28622. Epub 2019 Mar 27.

DOI:10.1002/jcb.28622
PMID:30916832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6619255/
Abstract

Long noncoding RNAs (lncRNAs) CASC11 is an oncogenic lncRNA in gastric cancer and colorectal cancer. Our study aimed to investigate the role of lncRNA CASC11 in bladder cancer. In this study we showed that plasma lncRNA CASC11 was upregulated, while plasma miRNA-150 was downregulated in patients with early-stage bladder cancer than in healthy controls. Altered expression of plasma lncRNA CASC11 and miRNA-150 separated patients with bladder cancer from healthy controls. lncRNA CASC11 expression was inversely correlated with miRNA-150 expression in patients with bladder cance but not in healthy controls. Overexpression of lncRNA CASC11 mediated the inhibition of miRNA-150 expression in cancer cells, while miRNA-150 overexpression did not significantly alter lncRNA CASC11 expression. lncRNA CASC11 overexpression promoted, while miRNA-150 overexpression inhibited cancer cell proliferation. miRNA-150 also attenuated the enhancing effects of lncRNA CASC11 overexpression on cancer cell proliferation. However, overexpression of lncRNA CASC11 showed no significant effects on cancer cell migration and invasion. Therefore, lncRNA CASC11 may promote cancer cell proliferation in bladder cancer, and the actions of lncRNA CASC11 are likely through miRNA-150.

摘要

长链非编码 RNA (lncRNA) CASC11 是胃癌和结直肠癌的致癌 lncRNA。本研究旨在探讨 lncRNA CASC11 在膀胱癌中的作用。在这项研究中,我们发现早期膀胱癌患者的血浆 lncRNA CASC11 上调,而血浆 miRNA-150 下调。血浆 lncRNA CASC11 和 miRNA-150 的改变表达将膀胱癌患者与健康对照者区分开来。lncRNA CASC11 的表达与膀胱癌患者的 miRNA-150 表达呈负相关,但与健康对照组无关。lncRNA CASC11 的过表达介导了 miRNA-150 在癌细胞中的抑制表达,而 miRNA-150 的过表达并没有显著改变 lncRNA CASC11 的表达。lncRNA CASC11 的过表达促进了,而 miRNA-150 的过表达抑制了癌细胞的增殖。miRNA-150 还减弱了 lncRNA CASC11 过表达对癌细胞增殖的增强作用。然而,lncRNA CASC11 的过表达对癌细胞的迁移和侵袭没有显著影响。因此,lncRNA CASC11 可能促进膀胱癌中癌细胞的增殖,lncRNA CASC11 的作用可能是通过 miRNA-150。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/6619255/6a52a470b8ba/JCB-120-13487-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/6619255/78147dd1ef11/JCB-120-13487-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/6619255/d72cc18f5479/JCB-120-13487-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/6619255/161a7c84a155/JCB-120-13487-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/6619255/8c6beaac093d/JCB-120-13487-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/6619255/6a52a470b8ba/JCB-120-13487-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/6619255/78147dd1ef11/JCB-120-13487-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/6619255/d72cc18f5479/JCB-120-13487-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/6619255/161a7c84a155/JCB-120-13487-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/6619255/8c6beaac093d/JCB-120-13487-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/6619255/6a52a470b8ba/JCB-120-13487-g005.jpg

相似文献

1
lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150.长链非编码 RNA CASC11 通过 microRNA-150 促进膀胱癌中的癌细胞增殖。
J Cell Biochem. 2019 Aug;120(8):13487-13493. doi: 10.1002/jcb.28622. Epub 2019 Mar 27.
2
LncRNA CASC11 promotes cancer cell proliferation in hepatocellular carcinoma by inhibiting miRNA-188-5p.长链非编码 RNA CASC11 通过抑制 miRNA-188-5p 促进肝癌细胞增殖。
Biosci Rep. 2019 Apr 30;39(4). doi: 10.1042/BSR20190251.
3
LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other.长链非编码 RNA AWPPH 通过与 miRNA-21 相互作用调节三阴性乳腺癌中癌细胞的增殖和化疗敏感性。
J Cell Biochem. 2019 Sep;120(9):14860-14866. doi: 10.1002/jcb.28747. Epub 2019 Apr 29.
4
LncRNA NEF is downregulated in triple negative breast cancer and correlated with poor prognosis.长链非编码 RNA NEF 在三阴性乳腺癌中下调,与预后不良相关。
Acta Biochim Biophys Sin (Shanghai). 2019 Apr 1;51(4):386-392. doi: 10.1093/abbs/gmz021.
5
lncRNA MORT Regulates Bladder Cancer Behaviors by Downregulating MicroRNA-146a-5p.长链非编码 RNA MORT 通过下调 microRNA-146a-5p 调控膀胱癌行为。
Nephron. 2020;144(7):351-357. doi: 10.1159/000506291. Epub 2020 Jun 17.
6
lncRNA TUC338 is a potential diagnostic biomarker for bladder cancer.长链非编码RNA TUC338是膀胱癌的一种潜在诊断生物标志物。
J Cell Biochem. 2019 Oct;120(10):18014-18019. doi: 10.1002/jcb.29104. Epub 2019 Jun 4.
7
LncRNA CASC11 promotes TGF-β1, increases cancer cell stemness and predicts postoperative survival in small cell lung cancer.长链非编码 RNA CASC11 促进 TGF-β1,增加小细胞肺癌中癌细胞的干性并预测术后生存。
Gene. 2019 Jul 1;704:91-96. doi: 10.1016/j.gene.2019.04.019. Epub 2019 Apr 6.
8
Long noncoding RNA HAND2-AS1 inhibits cancer cell proliferation, migration, and invasion in esophagus squamous cell carcinoma by regulating microRNA-21.长链非编码 RNA HAND2-AS1 通过调控 microRNA-21 抑制食管鳞癌细胞增殖、迁移和侵袭
J Cell Biochem. 2019 Jun;120(6):9564-9571. doi: 10.1002/jcb.28233. Epub 2018 Dec 5.
9
SP1 induced lncRNA CASC11 accelerates the glioma tumorigenesis through targeting FOXK1 via sponging miR-498.SP1 诱导的长链非编码 RNA CASC11 通过海绵吸附 miR-498 靶向 FOXK1 加速脑胶质瘤发生。
Biomed Pharmacother. 2019 Aug;116:108968. doi: 10.1016/j.biopha.2019.108968. Epub 2019 May 20.
10
LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of bladder cancer cells assurance guidelines.长链非编码RNA-SNHG7调节膀胱癌细胞的增殖、凋亡和侵袭 保障指南。 你提供的原文可能不太完整或表述有误,正常来说这样的内容作为一个句子结构不太合理,可能会影响准确理解和翻译。你可以检查一下原文是否准确。
J BUON. 2018 May-Jun;23(3):776-781.

引用本文的文献

1
Inhibition of LINC01048 decreases cell proliferation and induces the apoptosis in gastric cancer.抑制LINC01048可降低胃癌细胞的增殖并诱导其凋亡。
Discov Oncol. 2025 Jun 18;16(1):1143. doi: 10.1007/s12672-025-02994-2.
2
LINC02679 regulates TRIML2 to promote gastric cancer proliferation and invasion via targeting miR-5004-3p.LINC02679通过靶向miR-5004-3p调控TRIML2,促进胃癌的增殖和侵袭。
Noncoding RNA Res. 2025 Apr 1;13:1-14. doi: 10.1016/j.ncrna.2025.04.001. eCollection 2025 Aug.
3
lncRNA SNHG4 enhanced gastric cancer progression by modulating miR-409-3p/CREB1 axis.

本文引用的文献

1
LncRNA CASC11 promoted gastric cancer cell proliferation, migration and invasion in vitro by regulating cell cycle pathway.长链非编码 RNA CASC11 通过调控细胞周期通路促进胃癌细胞的增殖、迁移和侵袭。
Cell Cycle. 2018;17(15):1886-1900. doi: 10.1080/15384101.2018.1502574. Epub 2018 Sep 10.
2
A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells.一种长非编码 RNA 和 microRNA 相互作用的新机制:CCAT2 通过抑制结肠癌细胞中 miR-145 的成熟过程来调节其表达。
Mol Cancer. 2017 Sep 30;16(1):155. doi: 10.1186/s12943-017-0725-5.
3
Cancer incidence and mortality in China, 2013.
长链非编码RNA SNHG4通过调节miR-409-3p/CREB1轴增强胃癌进展。
Oncol Res. 2024 Dec 20;33(1):185-198. doi: 10.32604/or.2024.042281. eCollection 2025.
4
Innovation in CRC Research: Targeting SPACA6P-AS for Progression.结直肠癌研究中的创新:以SPACA6P-AS为进展靶点
J Biochem Mol Toxicol. 2024 Dec;38(12):e70039. doi: 10.1002/jbt.70039.
5
MIR210HG Accelerates the Progression of Colorectal Cancer and Affects the Function of Colorectal Cancer Cells by Downregulating miR-1226-3p.MIR210HG通过下调miR-1226-3p促进结直肠癌进展并影响结直肠癌细胞功能。
Turk J Gastroenterol. 2024 Nov 28;35(12):889-899. doi: 10.5152/tjg.2024.23669.
6
lncRNA CASC11 regulates the progress of delayed fracture healing via sponging miR-150-3p.长链非编码 RNA CASC11 通过海绵吸附 miR-150-3p 调控延迟骨折愈合的进程。
J Orthop Surg Res. 2024 Nov 14;19(1):757. doi: 10.1186/s13018-024-05226-5.
7
M2 Tumor Associate Macrophage- (TAM-) Derived lncRNA HISLA Promotes EMT Potential in Bladder Cancer.M2肿瘤相关巨噬细胞(TAM)衍生的长链非编码RNA HISLA促进膀胱癌的上皮-间质转化潜能
J Oncol. 2022 May 6;2022:8268719. doi: 10.1155/2022/8268719. eCollection 2022.
8
Silencing LINC00663 inhibits inflammation and angiogenesis through downregulation of NR2F1 via EBF1 in bladder cancer.沉默 LINC00663 通过 EBF1 下调 NR2F1 抑制膀胱癌中的炎症和血管生成。
RNA Biol. 2024 Jan;21(1):9-22. doi: 10.1080/15476286.2024.2368304. Epub 2024 Jun 18.
9
LncRNA ZFAS1 regulates ATIC transcription and promotes the proliferation and migration of hepatocellular carcinoma through the PI3K/AKT signaling pathway.长链非编码 RNA ZFAS1 通过 PI3K/AKT 信号通路调控 ATIC 转录,促进肝癌的增殖和迁移。
J Cancer Res Clin Oncol. 2024 Jul 13;150(7):351. doi: 10.1007/s00432-024-05877-1.
10
SH3BP5-AS1/IGF2BP2/VDAC2 Axis Promotes the Apoptosis and Ferroptosis of Bladder Cancer Cells.SH3BP5-AS1/IGF2BP2/VDAC2轴促进膀胱癌细胞的凋亡和铁死亡
Bladder Cancer. 2023 Mar 31;9(1):29-40. doi: 10.3233/BLC-211629. eCollection 2023.
2013年中国的癌症发病率和死亡率
Cancer Lett. 2017 Aug 10;401:63-71. doi: 10.1016/j.canlet.2017.04.024. Epub 2017 May 3.
4
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.膀胱癌发病率和死亡率:全球概述及最新趋势。
Eur Urol. 2017 Jan;71(1):96-108. doi: 10.1016/j.eururo.2016.06.010. Epub 2016 Jun 28.
5
Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.长链非编码RNA CASC11与hnRNP-K相互作用并激活WNT/β-连环蛋白通路,以促进结直肠癌的生长和转移。
Cancer Lett. 2016 Jun 28;376(1):62-73. doi: 10.1016/j.canlet.2016.03.022. Epub 2016 Mar 21.
6
Origins of Bladder Cancer.膀胱癌的起源。
Annu Rev Pathol. 2016 May 23;11:149-74. doi: 10.1146/annurev-pathol-012513-104703. Epub 2016 Feb 22.
7
Epidemiology, Incidence and Mortality of Bladder Cancer and their Relationship with the Development Index in the World.全球膀胱癌的流行病学、发病率、死亡率及其与发展指数的关系
Asian Pac J Cancer Prev. 2016;17(1):381-6. doi: 10.7314/apjcp.2016.17.1.381.
8
Bladder Cancer Mortality in the United States: A Geographic and Temporal Analysis of Socioeconomic and Environmental Factors.美国膀胱癌死亡率:社会经济与环境因素的地理和时间分析
J Urol. 2016 Feb;195(2):290-6. doi: 10.1016/j.juro.2015.07.091. Epub 2015 Jul 30.
9
miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation.微小RNA-150的下调通过激活AKT促进卵巢癌细胞对帕妥珠单抗的耐药性。
Arch Gynecol Obstet. 2015 Nov;292(5):1109-16. doi: 10.1007/s00404-015-3742-x. Epub 2015 May 19.
10
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.MPDL3280A(抗 PD-L1)治疗可导致转移性膀胱癌的临床活性。
Nature. 2014 Nov 27;515(7528):558-62. doi: 10.1038/nature13904.